Kara, FadilKiran, GuerkanMetindir, JaleOzan, HakanOzalp, SinanVardar, M. AliZeren, Handan2024-08-042024-08-0420090020-72921879-3479https://doi.org/10.1016/j.ijgo.2009.04.003https://hdl.handle.net/11616/94850Objective: To evaluate retrospectively the prevalence of cervical cytological abnormalities in patient records obtained from healthcare centers in Turkey. Method: Demographic characteristics and data on cervical cytological abnormalities were evaluated from patients who underwent flap tests in healthcare centers in 2007. Results: Data were collected from 33 healthcare centers totaling 140 334 patients. Overall, the prevalence of cervical cytological abnormalities was 1.8%; the prevalence of ASCUS, ASC-H, LSIL, HSIL, and AGC was 1.07%, 0.07%, 0.3%, 0.17%, and 0.08%, respectively. The prevalence of preinvasive cervical neoplasia was 1.7% and the prevalence of cytologically diagnosed invasive neoplasia was 0.06%. Conclusion: The abnormal cervical cytological prevalence rate in Turkey is lower than in Europe and North America. This might be due to sociocultural differences, lack of population-based screening programs, or a lower HPV prevalence rate in Turkey. (C) 2009 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.eninfo:eu-repo/semantics/closedAccessCervical cancerCervical cytologyCervical intraepithelial neoplasiasCervical neoplasiasPap testPap smearTurkeyArticle10632062091954130310.1016/j.ijgo.2009.04.0032-s2.0-68349139717Q1WOS:000269782800005Q3